Infectious keratitis in South Australia: Emerging resistance to cephazolin

European Journal of Ophthalmology

Volumn 15, Issue 1, 2005, Pages 23-26

  Leibovitch, I ^a   Lai, T F ^a   Senarath, L ^a   Hsuan, J ^a   Selva, Dinesh ^a,b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Antibiotics; Bacterial; Infection; Keratitis; Resistance

Indexed keywords

CEFALOTIN; CEFAZOLIN; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; AGED; ANTIBIOTIC RESISTANCE; AUSTRALIA; BACTERIUM CULTURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; FEMALE; HUMAN; KERATITIS; MAJOR CLINICAL STUDY; MALE; MORAXELLA; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; ADULT; ARTICLE; BACTERIAL EYE INFECTION; BACTERIUM; COMMUNICABLE DISEASE; CORNEA; DRUG EFFECT; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA; CEFAZOLIN; CEPHALOSPORIN RESISTANCE; COMMUNICABLE DISEASES, EMERGING; CORNEA; EYE INFECTIONS, BACTERIAL; FEMALE; HUMANS; KERATITIS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RETROSPECTIVE STUDIES; SOUTH AUSTRALIA;

EID: 15544386218     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210501500104     Document Type: Review

References (12)

1. Baum JL. Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms. Surv Ophthalmol 1979; 24: 97-105.
2. Jones DB. Initial therapy of suspected microbial corneal ulcers. II. Specific antibiotic therapy based on corneal smears. Surv Ophthalmol 1979; 24: 105-16.
3. Ormerod LD, Hertzmark E, Gomez DS, et al. Epidemiology of microbial keratitis in southern California: a multivariate analysis. Ophthalmology 1987; 94: 1322-33.
4. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000; 107: 1497-502.
5. Varaprasathan G, Miller K, Lietman T, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea 2004; 23: 360-4.
6. Fong CF, Tseng CH, Hu FR, Wang IJ, Chen WL, Hou YC. Clinical characteristics of microbial keratitis in a university hospital in Taiwan. Am J Ophthalmol 2004; 137: 329-36.
7. Laspina F, Samudio M, Cibils D, et al. Epidemiological characteristics of microbial results on patients with infectious corneal ulcers: a 13-year survey in Paraguay. Graefes Arch Clin Exp Ophthalmol 2004; 242: 204-9.
8. Chalita MR, Hofling-Lima AL, Paranhos A, Jr, Schor P, Belfort RB, Jr. Shifting trends in in-vitro antibiotic susceptibilities for common ocular isolates during a period of 15 years. Am J Ophthalmol 2004; 137: 43-51.
9. Asbell P, Stenson S. Ulcerative keratitis: survey of 30 years' experience. Arch Ophthalmol 1982; 100: 77-80.
10. Schaefer F, Bruttin O, Zografis L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol 2001; 85: 842-7.
11. Goldstein MH, Kowalski RP, Gordon J. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 1999; 106: 1313-8.
12. O'Brien T, Maguire M, Fink N, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis: report from the bacterial keratitis study research group. Arch Ophthalmol 1993; 113: 1257-65.